Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 573

1.

Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.

Yao M, Luo P, Hoffman HT, Chang K, Graham MM, Menda Y, Tan H, Buatti JM.

Am J Clin Oncol. 2007 Jun;30(3):264-70.

PMID:
17551303
[PubMed - indexed for MEDLINE]
2.

The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.

Yao M, Graham MM, Hoffman HT, Smith RB, Funk GF, Graham SM, Dornfeld KJ, Skwarchuk M, Menda Y, Buatti JM.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1001-10.

PMID:
15234033
[PubMed - indexed for MEDLINE]
3.

The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.

Yao M, Smith RB, Graham MM, Hoffman HT, Tan H, Funk GF, Graham SM, Chang K, Dornfeld KJ, Menda Y, Buatti JM.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):991-9. Epub 2005 Aug 15.

PMID:
16099601
[PubMed - indexed for MEDLINE]
4.

Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.

Ong SC, Schöder H, Lee NY, Patel SG, Carlson D, Fury M, Pfister DG, Shah JP, Larson SM, Kraus DH.

J Nucl Med. 2008 Apr;49(4):532-40. doi: 10.2967/jnumed.107.044792. Epub 2008 Mar 14.

PMID:
18344440
[PubMed - indexed for MEDLINE]
Free Article
5.

Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report.

Yao M, Smith RB, Hoffman HT, Funk GF, Lu M, Menda Y, Graham MM, Buatti JM.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):9-14. doi: 10.1016/j.ijrobp.2008.07.019. Epub 2008 Oct 17.

PMID:
18930358
[PubMed - indexed for MEDLINE]
6.

Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?

Rogers JW, Greven KM, McGuirt WF, Keyes JW Jr, Williams DW 3rd, Watson NE, Geisinger K, Cappellari JO.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):694-7.

PMID:
14967422
[PubMed - indexed for MEDLINE]
7.

Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.

Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA.

Arch Otolaryngol Head Neck Surg. 2007 May;133(5):435-40.

PMID:
17515501
[PubMed - indexed for MEDLINE]
8.

The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.

Brkovich VS, Miller FR, Karnad AB, Hussey DH, McGuff HS, Otto RA.

Laryngoscope. 2006 Jun;116(6):855-8.

PMID:
16735902
[PubMed - indexed for MEDLINE]
9.

Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.

Nayak JV, Walvekar RR, Andrade RS, Daamen N, Lai SY, Argiris A, Smith RP, Heron DE, Ferris RL, Johnson JT, Branstetter BF 4th.

Laryngoscope. 2007 Dec;117(12):2129-34.

PMID:
17921898
[PubMed - indexed for MEDLINE]
10.

[Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].

Di Martino E, Nowak B, Krombach GA, Sellhaus B, Hausmann R, Cremerius U, Büll U, Westhofen M.

Laryngorhinootologie. 2000 Apr;79(4):201-6. German.

PMID:
10838683
[PubMed - indexed for MEDLINE]
11.

Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.

Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, Kanegae K, Inubushi M, Tamaki N, Kitagawa Y.

Ann Nucl Med. 2008 Apr;22(3):177-84. doi: 10.1007/s12149-007-0097-9. Epub 2008 May 23.

PMID:
18498032
[PubMed - indexed for MEDLINE]
12.

Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.

Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, Yoshida M, Yonekura Y.

J Nucl Med. 2003 Feb;44(2):198-206.

PMID:
12571209
[PubMed - indexed for MEDLINE]
Free Article
13.

18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.

Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP.

J Natl Cancer Inst. 2008 May 21;100(10):712-20. doi: 10.1093/jnci/djn125. Epub 2008 May 13.

PMID:
18477804
[PubMed - indexed for MEDLINE]
Free Article
14.

Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.

Murakami R, Uozumi H, Hirai T, Nishimura R, Shiraishi S, Ota K, Murakami D, Tomiguchi S, Oya N, Katsuragawa S, Yamashita Y.

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):377-82. Epub 2007 Feb 22.

PMID:
17321066
[PubMed - indexed for MEDLINE]
15.

FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.

Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, Anzai Y, Haynor D, Lewellyn B, Mattes D, Meyer J, Phillips M, Leblanc M, Kinahan P, Krohn K, Eary J, Laramore GE.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):129-36.

PMID:
15629603
[PubMed - indexed for MEDLINE]
16.

Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.

Adams S, Baum RP, Stuckensen T, Bitter K, Hör G.

Eur J Nucl Med. 1998 Sep;25(9):1255-60.

PMID:
9724374
[PubMed - indexed for MEDLINE]
17.

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY.

J Nucl Med. 2009 Jan;50(1):24-9. doi: 10.2967/jnumed.108.055806. Epub 2008 Dec 17.

PMID:
19091901
[PubMed - indexed for MEDLINE]
Free Article
18.

PET monitoring of therapy response in head and neck squamous cell carcinoma.

Schöder H, Fury M, Lee N, Kraus D.

J Nucl Med. 2009 May;50 Suppl 1:74S-88S. doi: 10.2967/jnumed.108.057208. Epub 2009 Apr 20. Review.

PMID:
19380408
[PubMed - indexed for MEDLINE]
Free Article
19.

Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.

Andrade RS, Heron DE, Degirmenci B, Filho PA, Branstetter BF, Seethala RR, Ferris RL, Avril N.

Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1315-22. Epub 2006 Jun 5.

PMID:
16750327
[PubMed - indexed for MEDLINE]
20.

Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.

Stokkel MP, ten Broek FW, van Rijk PP.

Eur J Nucl Med. 1999 May;26(5):499-503.

PMID:
10382094
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk